Industry reports
Editor highlights

Drug and Medication Analysis & Statistics in the United Kingdom, November 2012 (p3)

You might be interested in: drug, vaccine, insulin, more »

» Purchase Premium Reports

61-90 of about 100 reports
Fluvirin (Seasonal Influenza Vaccine) Forecast and Market Analysis

Fluvirin (Seasonal Influenza Vaccine) Forecast and Market Analysis

  • $ 3 495
  • Industry report
  • November 2012
  • by Global Data

Fluvirin (Seasonal Influenza Vaccine) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Fluvirin (Seasonal Influenza Vaccine) Forecast and Market ...

  • Industries : Drug and Medication
  • Countries : United States, United Kingdom, World
FluMist (Seasonal Influenza Vaccines) Forecast and Market Analysis

FluMist (Seasonal Influenza Vaccines) Forecast and Market Analysis

  • $ 3 495
  • Industry report
  • November 2012
  • by Global Data

FluMist (Seasonal Influenza Vaccines) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?FluMist (Seasonal Influenza Vaccines) Forecast and Market ...

  • Industries : Drug and Medication
  • Countries : China, World, United States, Spain, Italy, Germany, Europe, United Kingdom
Vaxigrip (Seasonal Influenza Vaccines) Forecast and Market Analysis

Vaxigrip (Seasonal Influenza Vaccines) Forecast and Market Analysis

  • $ 3 495
  • Industry report
  • November 2012
  • by Global Data

Vaxigrip (Seasonal Influenza Vaccines) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Vaxigrip (Seasonal Influenza Vaccines) Forecast and Market ...

  • Industries : Drug and Medication
  • Countries : China, World, Italy, France, Germany, India, United Kingdom, Spain, Europe
Optaflu (Seasonal Influenza Vaccine) Forecast and Market Analysis

Optaflu (Seasonal Influenza Vaccine) Forecast and Market Analysis

  • $ 3 495
  • Industry report
  • November 2012
  • by Global Data

Optaflu (Seasonal Influenza Vaccine) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Optaflu (Seasonal Influenza Vaccine) Forecast and Market ...

  • Industries : Drug and Medication
  • Countries : United States, Spain, Italy, France, Germany, World, Europe, United Kingdom
Agrippal (Seasonal Influenza Vaccine) Forecast and Market Analysis

Agrippal (Seasonal Influenza Vaccine) Forecast and Market Analysis

  • $ 3 495
  • Industry report
  • November 2012
  • by Global Data

Agrippal (Seasonal Influenza Vaccine) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Agrippal (Seasonal Influenza Vaccine) Forecast and Market ...

  • Industries : Drug and Medication
  • Countries : Spain, Italy, Germany, India, China, World, France, Japan, United States, United Kingdom, Europe
Fluzone IntraDermal (Seasonal Influenza Vaccines) Forecast and Market Analysis

Fluzone IntraDermal (Seasonal Influenza Vaccines) Forecast and Market Analysis

  • $ 3 495
  • Industry report
  • November 2012
  • by Global Data

Fluzone IntraDermal (Seasonal Influenza Vaccines) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Fluzone IntraDermal (Seasonal Influenza Vaccines) ...

  • Industries : Drug and Medication
  • Countries : World, United States, France, Germany, United Kingdom, China, Europe
Afluria (Seasonal Influenza Vaccines) Forecast and Market Analysis

Afluria (Seasonal Influenza Vaccines) Forecast and Market Analysis

  • $ 3 495
  • Industry report
  • November 2012
  • by Global Data

Afluria (Seasonal Influenza Vaccines) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Afluria (Seasonal Influenza Vaccines) Forecast and Market ...

  • Industries : Drug and Medication
  • Countries : China, World, United States, Spain, Italy, France, Germany, Japan, India, United Kingdom, Europe
Home Office - Strategic SWOT Analysis Review

Home Office - Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • November 2012
  • by Global Data

Summary The Home Office is the UK government department engaged in police, drugs policy, crime, counter-terrorism, immigration and passports. Home Office's major responsibilities include Counter-terrorism, ...

  • Industries : Drug and Medication
  • Countries : United Kingdom
Seasonal Influenza Vaccines Market in Top Seven Countries to 2018 - Next Generation Quadrivalent Vaccines to Dominate the Market by Offering Broader Protection via Single Dose

Seasonal Influenza Vaccines Market in Top Seven Countries to 2018 - Next Generation Quadrivalent Vaccines to Dominate the Market by Offering Broader Protection via Single Dose

  • $ 3 500
  • Industry report
  • October 2012
  • by GBI Research

Seasonal Influenza Vaccines Market in Top Seven Countries to 2018 - Next Generation Quadrivalent Vaccines to Dominate the Market by Offering Broader Protection via Single Dose Summary GBI Research, ...

  • Industries : Drug and Medication
  • Countries : Japan, Germany, Spain, Italy, France, United States, Europe, United Kingdom
United Kingdom Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

United Kingdom Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • October 2012
  • by Business Monitor International

- In July 2011, Southern Cross, the UK’s biggest care home operator, ceased to exist. The industry player announced it was closing down after the landlords owning all 752 of its care homes said they ...

  • Industries : Drug and Medication
  • Countries : United Kingdom
MarketVIEW: hepatitis A vaccines (travel)

MarketVIEW: hepatitis A vaccines (travel)

  • $ 5 995
  • Industry report
  • October 2012
  • by VacZine Analytics Group Of Assay Advantage Ltd

Hepatitis A (HAV) produces a self-limiting liver disease which can produce a range of symptoms such as nausea, anorexia, fever, malaise or abdominal pain. Unlike Hepatitis B and C viruses it does not cause ...

  • Industries : Drug and Medication
  • Countries : United States, North America, World, South Korea, Europe, Australia, Brazil, Canada, United Kingdom, Sweden, Spain, Norway, Italy, France, Germany, Finland, Denmark
Antibiotics Markets - Top 10 Global Countries Package

Antibiotics Markets - Top 10 Global Countries Package

  • $ 5 174
  • Industry report
  • September 2012
  • by Global Research & Data Services

This market research report package offers a perspective on the actual market situation, trends and future outlook for antibiotics in the top 10 global countries. The studies provide essential market information ...

  • Industries : Drug and Medication
  • Countries : World, United States, United Kingdom, Canada, Russian Federation, Italy, France, Germany, Japan, India, China, Europe
Antibiotics Market in United Kingdom to 2016

Antibiotics Market in United Kingdom to 2016

  • $ 652
  • Industry report
  • September 2012
  • by Global Research & Data Services

This market research report offers a perspective on the actual market situation, trends and future outlook for antibiotics in United Kingdom. The study provides essential market information for decision-makers ...

  • Industries : Drug and Medication
  • Countries : United Kingdom
Global Active Pharmaceutical Ingredients (API) and High Potency API (HPAPI) Industry Outlook to 2016 - Shifting Focus Towards Biotechnology

Global Active Pharmaceutical Ingredients (API) and High Potency API (HPAPI) Industry Outlook to 2016 - Shifting Focus Towards Biotechnology

  • $ 1 200
  • Industry report
  • September 2012
  • by Ken Research Private

EXECUTIVE SUMMARY The report titled ?Global Active Pharmaceutical Ingredients (API) and High Potency API (HPAPI) Industry Outlook to 2016 - Shifting Focus Towards Biotechnology? provides a comprehensive ...

  • Industries : Drug and Medication
  • Countries : World, Europe, North America, India, China, United States, Canada, Italy, Germany, France, Spain, Japan, United Kingdom, Asia
Market Forecasts: Seasonal Influenza Vaccines

Market Forecasts: Seasonal Influenza Vaccines

  • $ 6 400
  • Industry report
  • August 2012
  • by Datamonitor

The large public attention associated with the influenza A (H1N1, swine flu) pandemic in 2009 increased awareness of the importance of seasonal influenza vaccination. Datamonitor predicts that the seasonal ...

  • Industries : Drug and Medication
  • Countries : United States, United Kingdom
Market Forecasts: Seasonal Influenza Vaccines - Broadened recommendations and increased awareness boost sales in the seasonal influenza vaccine market

Market Forecasts: Seasonal Influenza Vaccines - Broadened recommendations and increased awareness boost sales in the seasonal influenza vaccine market

  • $ 11 400
  • Industry report
  • August 2012
  • by Datamonitor

The large public attention associated with the influenza A (H1N1, swine flu) pandemic in 2009 increased awareness of the importance of seasonal influenza vaccination. Datamonitor predicts that the seasonal ...

  • Industries : Drug and Medication
  • Countries : France, Spain, Italy, Germany, Japan, United States, United Kingdom, Europe
UK Drug Sector: Sector Report

UK Drug Sector: Sector Report

  • $ 800
  • Industry report
  • July 2012
  • by Daedal Research

This industry profile is an essential tool to help your company gain an in-depth knowledge and competitive advantage in the industry. The profile is an assimilation of insider knowledge, market characteristics ...

  • Industries : Drug and Medication
  • Countries : United Kingdom
MarketVIEW: Candida vaccines

MarketVIEW: Candida vaccines

  • $ 7 995
  • Industry report
  • July 2012
  • by VacZine Analytics Group Of Assay Advantage Ltd

Candida yeasts cause Candidiasis which is a fungal infection commonly found in humans. Infections can occur in the female Genital area "vulvovaginal candidiasis" of which nearly 75% of all adult women ...

  • Industries : Drug and Medication
  • Countries : Australia, Canada, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe, World
MarketVIEW: Herpes Simplex Virus (TX) vaccines

MarketVIEW: Herpes Simplex Virus (TX) vaccines

  • $ 8 995
  • Industry report
  • July 2012
  • by VacZine Analytics Group Of Assay Advantage Ltd

Herpes Simplex Virus (HSV) is a sexually transmitted virus which is a major cause of genital herpes (GH). Although most individuals infected with HSV-2 have minimal signs of infection, the disease is life-long ...

  • Industries : Drug and Medication
  • Countries : United States, United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, World
Biopharmaceutical: Hepatitis A Preventive Vaccines

Biopharmaceutical: Hepatitis A Preventive Vaccines

  • $ 3 995
  • Company report
  • June 2012
  • by Global Data

GlobalData, the market analysis specialist, has released its new report, ??. The report is an essential source of information and analysis on the global Hepatitis A Preventive Vaccines industry . The ...

  • Industries : Drug and Medication
  • Countries : Japan, Spain, Italy, France, Germany, United States, World, Europe, United Kingdom
UK Drug Market Research

UK Drug Market Research

  • $ 600
  • Industry report
  • June 2012
  • by Koncept Analytics

This market profile helps to gain an insight into the evolution of the market and competitive dynamics prevalent in the industry . It discusses the significant developments in the market and analyzes the ...

  • Industries : Drug and Medication
  • Countries : United Kingdom
MarketVIEW: Cytomegalovirus (CMV) vaccines

MarketVIEW: Cytomegalovirus (CMV) vaccines

  • $ 9 995
  • Industry report
  • June 2012
  • by VacZine Analytics Group Of Assay Advantage Ltd

Cytomegalovirus (CMV) is a member of the herpesvirus family and is widely prevalent throughout the population. In the US around 50-80% of adults are infected by 40 years of age (US CDC figures) whereas ...

  • Industries : Drug and Medication
  • Countries : United States, Canada, Spain, Italy, France, Germany, Japan, United Kingdom, Europe, World
MarketVIEW: Cytomegalovirus vaccines

MarketVIEW: Cytomegalovirus vaccines

  • $ 9 995
  • Industry report
  • June 2012
  • by VacZine Analytics Group Of Assay Advantage Ltd

Cytomegalovirus (CMV) is a member of the herpesvirus family and is widely prevalent throughout the population. In the US around 50-80% of adults are infected by 40 years of age (US CDC figures) whereas ...

  • Industries : Drug and Medication
  • Countries : United States, Canada, Spain, Italy, France, Germany, Japan, United Kingdom, Europe, World
Market and Product Projections : Non-Insulin Antidiabetics ? - Incretin mimetics face off Market Overview in type 2 diabetes

Market and Product Projections : Non-Insulin Antidiabetics ? - Incretin mimetics face off Market Overview in type 2 diabetes

  • $ 11 400
  • Industry report
  • May 2012
  • by Datamonitor

The 2011'20 projection period will see the loss of exclusivity for the leading non-insulin antidiabetic Actos franchise, while new launches include the first once-weekly GLP-1 agonists and the oral SGLT-2 ...

  • Industries : Drug and Medication
  • Countries : Japan, Spain, Italy, France, Germany, United States, Europe, United Kingdom
Insulin - United Kingdom

Insulin - United Kingdom

  • $ 652
  • Industry report
  • May 2012
  • by Global Research & Data Services

This market research report offers a perspective on the actual market situation, trends and future outlook for insulin in United Kingdom. The study provides essential market information for decision-makers ...

  • Industries : Drug and Medication
  • Countries : United Kingdom
MarketVIEW - Staphylococcus aureus vaccines

MarketVIEW - Staphylococcus aureus vaccines

  • $ 9 995
  • Industry report
  • April 2012
  • by VacZine Analytics Group Of Assay Advantage Ltd

Gram-positive Staphylococcus aureus is an opportunistic pathogen and a major cause of patient morbidity and mortality, especially in "at risk" populations. The organism can cause a wide range of infections ...

  • Industries : Drug and Medication
  • Countries : United States, France, Germany, Europe, Australia, Canada, United Kingdom, Spain, Italy, Japan, World
Haemophilus Influenzae Type B (Hib) Vaccine - Pipeline Assessment and Market Forecasts to 2019

Haemophilus Influenzae Type B (Hib) Vaccine - Pipeline Assessment and Market Forecasts to 2019

  • $ 3 995
  • Company report
  • February 2012
  • by Global Data

Haemophilus Influenzae Type B (Hib) Vaccine - Pipeline Assessment and Market Forecasts to 2019 Summary GlobalData, the industry analysis specialist, has released its new report, ?Haemophilus Influenzae ...

  • Industries : Drug and Medication
  • Countries : World, Japan, Spain, Italy, France, Germany, United States, Europe, United Kingdom
Amylin Pharmaceuticals, Inc.: PharmaVitae Report

Amylin Pharmaceuticals, Inc.: PharmaVitae Report

  • $ 5 700
  • Company report
  • February 2012
  • by Datamonitor

This analysis examines the historical and forecast performance for Amylin in the prescription pharmaceutical sector. The profile encompasses key product analysis and forecasts, pipeline assessment, and ...

  • Industries : Drug and Medication
  • Countries : United Kingdom
Tiered Pricing Strategies in Emerging Markets

Tiered Pricing Strategies in Emerging Markets

  • $ 695
  • Industry report
  • February 2012
  • by Firstword Pharma

For the pharmaceutical industry, emerging markets are dynamic, full of potential and offer solid growth at a time when established markets are contracting. But they also pose a significant problem: extreme ...

  • Industries : Drug and Medication
  • Countries : United Kingdom, Switzerland, France
MarketVIEW: universal pneumo vaccines

MarketVIEW: universal pneumo vaccines

  • $ 9 995
  • Industry report
  • January 2012
  • by VacZine Analytics Group Of Assay Advantage Ltd

Vaccines to prevent serious infections caused by Streptococcus pneumoniae or "pneumo" currently form the largest component of the global vaccine market ($4 - 5bn/yr). Notable examples are Prevnar/Prevena ...

  • Industries : Drug and Medication
  • Countries : South Korea, Europe, World, Australia, Netherlands, United States, Canada, Spain, Portugal, Poland, Italy, Greece, France, Germany, Belgium, Japan, United Kingdom, Bangladesh, Brazil, Mexico, Gambia

» View Public Reports

About 200 reports

Drug and Medication in The United Kingdom : Innovation and Technology Trends

  • Industry report
  • January 2014
  • 22 pages

... Addressing hta for companion diagnostics and differential pricing 7. Price flexibility by indication / subgroup and outcomes-based ced/ pbrsa schemes are important to effective use of drugs p ...


» Read our Company Profiles

2 Companies

GlaxoSmithKline P.L.C.

United States

GlaxoSmithKline PLC

United Kingdom

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.